Filing Details
- Accession Number:
- 0001181431-13-016039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-11 17:06:56
- Reporting Period:
- 2013-03-07
- Filing Date:
- 2013-03-11
- Accepted Time:
- 2013-03-11 17:06:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238913 | D Kim Blickenstaff | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-07 | 60,000 | $9.38 | 60,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-07 | 15,200 | $46.18 | 44,800 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-08 | 31,300 | $46.92 | 13,500 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-08 | 13,500 | $47.88 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-03-07 | 60,000 | $0.00 | 60,000 | $9.38 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-06-15 | No | 4 | M | Direct |
Footnotes
- The shares were sold at prices ranging from $45.57 to $46.54333. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $46.57 to $47.56333. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $47.57 to $48.16. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
